translatepress-multilingual domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114
Se ha desarrollado un nuevo fármaco para el tratamiento de un tipo de cáncer cerebral, llamado glioma de bajo grado con mutación IDH. aprobado El 6 de agosto, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA) aprobó el uso de este medicamento. El nuevo y prometedor fármaco se deriva de un descubrimiento genético realizado en 2008 en la Centro Oncológico Johns Hopkins Kimmel.
